ASTRO 2022 | Enhancing clinical trial diversity via artificial intelligence (AI)

James Zou, PhD, Stanford University, Stanford, CA, discusses combining artificial intelligence (AI) with large-scale electronic health record (EHR) data to aid in designing clinical trials with a purpose to increase diversity and inclusivity within clinical trials. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.